All News
#acr19 @RheumNow Pearls by Dr Sterling West
1. Pain w/ measuring BP (BP cuff test) sens 69%, spec 80%= FM
2. Recurrent troch/anserine bursitis - take off shoes and watch them walk might see hallux rigidis, over pronation- (my hint: look for leg length discrepancy as well)
k dao KDAO2011 ( View Tweet)
#acr19 @RheumNow Pearls by Dr Sterling West: mnemonics to help with dermatomes —- trainees these have been on the boards!!! https://t.co/2yZ39fIYfQ
k dao KDAO2011 ( View Tweet)
Wow. When can we have the mouthguard to measure uric acid levels?
#ACR19 @rheumnow 5T027 https://t.co/L5ytR1jxJT
Dr Irwin Lim _connectedcare ( View Tweet)
Likely to be practice-changing one day - abstr#2091 shows increased seroprotection w/high dose influenza vaccine in RA patients, including those <65 yrs
@RheumNow #ACR19 #whyivaccinate
Cassandra Calabrese CCalabreseDO ( View Tweet)
My write-up of data on IL-17 Inhibitors In Non-Radiographic Axial SpA presented here at #ACR19 @rheumnow https://t.co/5emwrGX6zF
Philip Robinson philipcrobinson ( View Tweet)
RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Novartis. All content chosen by RheumNow and its faculty.
Dr. John Cush RheumNow ( View Tweet)
Exciting *US orderable* new bio marker in #lupus CB-CAPS = cell bound complement activation products. Nicely tracks disease #ACR19 @RheumNow https://t.co/J1pmyGqmyY
Philip Robinson philipcrobinson ( View Tweet)
#acr19 @rheumnow Hench lecture: Dr Reveille
HLAB15 may be a marker for peripheral arthritis in pts w/AS (OR 1.9)
k dao KDAO2011 ( View Tweet)
Bullish on value of Polygenic Risk scores to help diagnose Axial SpA (not commercially available yet)
#ACR19 @rheumnow 5T004 Reveille https://t.co/OfQYzx6yGL
Dr Irwin Lim _connectedcare ( View Tweet)
VERVE results - Live zoster vaccine safe and effective in >600 patients with autoimmune diseases treated wth TNFi abstr#0824 @RheumNow #ACR19
Cassandra Calabrese CCalabreseDO ( View Tweet)
Buyon reminds us how highly sensitive ELISA based anti-DNA assays are, caution required because more sensitive tests are often negative (crithidia/RIA) #ACR19 @RheumNow Abs 5T002 https://t.co/XN8Sfy1yHJ
Philip Robinson philipcrobinson ( View Tweet)
2.9% of this cohort had ONSET of Inflammatory Back pain after age of 50. We don’t study this group.
#ACR19 @rheumnow 5T004 Reveille https://t.co/p023BlGxPN
Dr Irwin Lim _connectedcare ( View Tweet)
@SurajDhoot2 @RheumNow the speaker stated most think a tophus is just a crystal collection, but within the tophus there are a lot of biologic activity: cytokines, fibroblasts, macrophages.... driven by the crystals. The treatment is the same (ULT)but it might also explain why IL-1 inh helps inflmm
k dao KDAO2011 ( View Tweet)
#acr19 @rheumnow Hench Lecture w/Dr J Reveille on back pain to HLA B27
20% of people 20-50 yrs old in US have chronic back pain. How many of you have back pain now?
k dao KDAO2011 ( View Tweet)
Important point that we must adjust for duration of treatment when looking at irAEs as a biomatker for tumor response to ICI- even when you do, however, any grade irAE is associated with better outcome! #ACR19 @LCalabreseDO @CCalabreseDO @drdavidliew
Laura Cappelli cappelliMD ( View Tweet)
@cappelliMD @LCalabreseDO @CCalabreseDO Jeffrey Weber today at #ACR19: "I'm a T cell chauvinist... turns out that B cells are extraordinarily important in the onset of irAEs." Autoantibodies important in irAEs - Jeffrey Weber's convinced!
shout out to @jessbq @ONJ_TILs
David Liew drdavidliew ( View Tweet)
PMR treatment with no oral steroids, low dose MTX and occasional steroid injections? Surprising and intriguing: little success previously in non-steroid paradigm in PMR, more data on this please, def worth further testing!
Hospital 12 de Octubre, Madrid #ACR19 ABST0742 @RheumNow https://t.co/I15GA4gjPw
David Liew drdavidliew ( View Tweet)
Takayasu's arteritis isn't just one, homogenous disease - and different phenotypes have different outcomes. Interesting from @petercgrayson's group at @NIH_NIAMS #ACR19 ABST0753 @RheumNow https://t.co/sWxUGaCRq2
David Liew drdavidliew ( View Tweet)
You heard it from the oncologist- autoimmune disease is NOT an exclusion criterion for being treated with immune checkpoint inhibitors! Flare is common but manageable #ACR19
Laura Cappelli cappelliMD ( View Tweet)
Here are the results of the poll. Thanks for participating. We look forward to more studies that will help us answer this important question 🤫 #ACR19 @RheumNow https://t.co/q3AJZS6spj
Dr. Antoni Chan synovialjoints ( View Tweet)